These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 7847823)
1. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F; Poupon MF; Le Chevalier T Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous cytogenetic abnormalities in small cell lung cancer cell lines. Morstyn G; Brown J; Novak U; Gardner J; Bishop J; Garson M Cancer Res; 1987 Jun; 47(12):3322-7. PubMed ID: 3034409 [TBL] [Abstract][Full Text] [Related]
3. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line. Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350 [TBL] [Abstract][Full Text] [Related]
4. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
5. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines. Liu C; Tsao MS Am J Pathol; 1993 Feb; 142(2):413-23. PubMed ID: 8382008 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327 [TBL] [Abstract][Full Text] [Related]
7. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Graziano SL; Cowan BY; Carney DN; Bryke CR; Mitter NS; Johnson BE; Mark GE; Planas AT; Catino JJ; Comis RL Cancer Res; 1987 Apr; 47(8):2148-55. PubMed ID: 3030544 [TBL] [Abstract][Full Text] [Related]
9. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
10. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
11. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Gazdar AF; Carney DN; Nau MM; Minna JD Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258 [TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312 [TBL] [Abstract][Full Text] [Related]
13. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE; Bepler G; Kubasch M; Havemann K Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028 [TBL] [Abstract][Full Text] [Related]
14. Genome analysis of small cell lung cancer (SCLC) and clinical significance. Buys CH; Osinga J; van der Veen AY; Mooibroek H; van der Hout AH; de Leij L; Postmus PE; Carritt B Eur J Respir Dis Suppl; 1987; 149():29-36. PubMed ID: 3034645 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004 [TBL] [Abstract][Full Text] [Related]
16. [Recent progress in the biology of small cell bronchial carcinoma]. Thomas F; Arriagada R; Le Chevalier T; Poupon MF Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257 [TBL] [Abstract][Full Text] [Related]
17. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł. Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793 [TBL] [Abstract][Full Text] [Related]
18. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030 [TBL] [Abstract][Full Text] [Related]
19. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice. Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]